CN104606154A - Thyroid tablet composition freeze-dried tablet and preparation method thereof - Google Patents

Thyroid tablet composition freeze-dried tablet and preparation method thereof Download PDF

Info

Publication number
CN104606154A
CN104606154A CN201410826989.1A CN201410826989A CN104606154A CN 104606154 A CN104606154 A CN 104606154A CN 201410826989 A CN201410826989 A CN 201410826989A CN 104606154 A CN104606154 A CN 104606154A
Authority
CN
China
Prior art keywords
tablet
thyroid
solution
composition freeze
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410826989.1A
Other languages
Chinese (zh)
Inventor
王丹
石金友
汪金灿
郝结兵
吴函峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan Weikang Pharmaceutical Qianshan Co Ltd
Original Assignee
Hainan Weikang Pharmaceutical Qianshan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan Weikang Pharmaceutical Qianshan Co Ltd filed Critical Hainan Weikang Pharmaceutical Qianshan Co Ltd
Priority to CN201410826989.1A priority Critical patent/CN104606154A/en
Publication of CN104606154A publication Critical patent/CN104606154A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention provides a thyroid tablet composition freeze-dried tablet and a preparation method thereof, and relates to the technical field of medicines and medicine production. The thyroid tablet composition freeze-dried tablet comprises thyroid tablet, starch and cane sugar, wherein the starch and the cane sugar are taken as auxiliary materials. Common corn starch is treated by a heating technique, so that the bonding and disintegration functions of the starch in the tablet can be improved, and the formability of the tablet is improved. The thyroid tablet composition freeze-dried tablet only needs two auxiliary materials namely the starch and the cane sugar. The thyroid tablet composition freeze-dried tablet adopts a twice-temperature-reduction and twice-temperature-rise freeze-drying technique, and due to twice temperature reduction and twice temperature rise, the formability of the tablet is better, and the dissolution rate of the tablet is improved, so that the bioavailability of the tablet is improved; the tablet overcomes the defects of a common thyroid tablet, the types and the quantities of the auxiliary materials in the thyroid tablet are reduced, the dissolution rate of the tablet is large, the bioavailability of the tablet is high, and the curative effect and the safety of clinical medication are ensured.

Description

A kind of thyroid tablet composition freeze-drying sheet and preparation method thereof
Technical field
The present invention relates to medicine and medical production technical field, be specifically related to a kind of thyroid tablet composition freeze-drying sheet and preparation method thereof.
Background technology
This product Main Ingredients and Appearance is: be the thyroid body getting the edible animals such as pig, cattle, sheep, and removing connective tissue and fat, rub, dehydration, defat, the temperature below 60 DEG C is dry, and porphyrize is made.
Existing clinical common dosage forms is the thyroid tablet of synthetic.This product is thyroxin medicine, induction nascent protein comprises the synthesis of specific enzymes system, Function protein matter, carbohydrate and fat three large materials, and water, the metabolism of salt and vitamin. due to thyroxin inducing cell film Na+-K+ pump synthesis and strengthen its vigor, energy metabolism is strengthened. thyroxin (mainly T3) combines with core internal specific receptor, there is change of configuration in the latter, form dimer, special sequence on the receptor activated and DNA, thyroxin response element combines, thus the transcript and expression of controlling gene (target gene of thyroxin), promote the synthesis of new protein (being mainly enzyme).
In common thyroid tablet containing supplementary product kind and quantity more, generally will use filler, lubricant, disintegrating agent, adhesive, correctives etc., its disintegration time reaches 12 minutes, and bioavailability is lower.And increasing research shows that impurity in the incompatibility of the toxic and side effects of adjuvant itself, adjuvant and principal agent, adjuvant etc. all can have an impact to the safety of medicine.
Therefore, provide one can overcome above-mentioned shortcoming, select suitable adjuvant and technique, reduce supplementary product kind and consumption in thyroid tablet, improve thyroid tablet bioavailability, ensure that the safety of clinical application all has positive effect.
Traditional lyophilizing tablet can improve bioavailability, but still need use the adjuvant such as mannitol, gelatin.And mannitol has certain biological activity, gelatin resource-constrained and perishable.
Starch is the basic adjuvant of oral solid formulation, it is polymerized by glucose molecule, and be commonly used for adhesive, diluent and disintegrating agent in tablets, it is cheap and easy to get, to human-body safety, but being used alone starch has no report as adjuvant freeze-dry process production thyroid tablet lyophilizing sheet.
Summary of the invention
Technical problem to be solved by this invention is the defect overcoming prior art, and propose a kind of thyroid tablet composition freeze-drying sheet and preparation method thereof further, said preparation adjuvant is few, good stability, and bioavailability is high.
Technical problem to be solved by this invention realizes by the following technical solutions:
A kind of thyroid tablet composition freeze-drying sheet, adjuvant is done with starch and sucrose, produce with freeze-dry process, this tablet overcomes the shortcoming of above-mentioned common thyroid blade, decrease supplementary product kind and consumption in thyroid blade, this sheet dissolution is large, and bioavailability is high, ensure that curative effect and the safety of clinical application.
A kind of thyroid tablet composition freeze-drying sheet, is prepared from by following raw material:
A preparation method for thyroid tablet composition freeze-drying sheet, comprises step as follows:
A, take the starch of component amount, add a certain amount of purified water and stir, by pH adjusting agent, the pH value of solution is controlled between 4-6, be then heated to 72 DEG C, be incubated 20 minutes, make the corn starch solution of 5 ~ 15% (W/V);
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution;
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, is down to room temperature and obtains Semen Maydis-sucrose solution;
D, take thyroid tablet 10 grams, add in 1L Semen Maydis-sucrose solution, stir 25 ~ 35 minutes;
Medicinal liquid is sub-packed in drug-containing dish after measuring thyroid tablet content by E, medicinal liquid, each drug-containing dish dress 1.0ml;
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs; Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain thyroid tablet composition freeze-drying sheet.
Described starch selects corn starch, preferably the corn starch solution of 10% (W/V).
Beneficial effect of the present invention is:
The preparation method of a kind of thyroid tablet composition freeze-drying sheet of the present invention, heating process process is carried out to common corn starch, starch bonding in tablets, disintegration can be improved, improve the mouldability of tablet, in thyroid tablet composition freeze-drying sheet, dosage of sucrose is 8.5% (W/V), it is the hardness reinforcer of this tablet, and plays flavored action.Thyroid tablet composition freeze-drying sheet only needs starch and sucrose two kinds of adjuvants.The freeze-dry process of two liters falls in thyroid tablet composition freeze-drying sheet employing two, and twice cooling, twice intensification can make sheet mouldability better, and shorten the disintegration time of tablet, improve the bioavailability of tablet.
Detailed description of the invention
The technological means realized to make the present invention, creation characteristic, reaching object and effect is easy to understand, below in conjunction with specific embodiment, set forth the present invention further, but following embodiment being only the preferred embodiments of the present invention, and not all.Based on the embodiment in embodiment, those skilled in the art under the prerequisite not making creative work obtain other embodiment, all belong to the protection domain of this patent.
Embodiment 1
A, take the corn starch of 100g, the purified water adding 900ml stirs, and controls 6.5, is then heated to 72 DEG C, keep 120 minutes, make the corn starch solution of 9% (W/V) by pH adjusting agent by the pH value of solution.
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution.
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, after solution be down to room temperature obtain Semen Maydis-sucrose solution.
D, take thyroid tablet 10g, add in 1L Semen Maydis-sucrose solution, stir 30 minutes.
Medicinal liquid is sub-packed in drug-containing dish after measuring thyroid tablet content by E, medicinal liquid, each drug-containing dish dress 1.0ml.
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs.Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain thyroid tablet composition freeze-drying sheet.
Embodiment 2
A, take the corn starch of 130g, the purified water adding 900ml stirs, and controls at 4-6, is then heated to 72 DEG C, keep 120 minutes, make the corn starch solution of 13% (W/V) by pH adjusting agent by the pH value of solution.
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution.
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, after solution be down to room temperature obtain Semen Maydis-sucrose solution.
D, take thyroid tablet 10 grams (by 1000 calculations), add 1L Semen Maydis-sucrose solution, stir 30 minutes.
Medicinal liquid is sub-packed in drug-containing dish after measuring thyroid tablet content by E, medicinal liquid, each drug-containing dish dress 1.0ml.
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs.Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain thyroid tablet composition freeze-drying sheet.
Experimental data
The thyroid tablet composition freeze-drying sheet that above-described embodiment is obtained carries out following quality research test:
1, hardness, friability contrast test
Get thyroid tablet composition freeze-drying sheet prepared by above-described embodiment respectively and thyroid tablet ordinary tablet (commercially available) detects friability and hardness by " Chinese Pharmacopoeia " version in 2010 two annex X G inspection techniques, contrast, the results are shown in following table:
Sample Hardness/N Friability
Embodiment 1 62 <1%
Embodiment 2 65 <1%
Ordinary tablet 70 <1%
Experimental data shows, thyroid tablet composition freeze-drying sheet and ordinary tablet without significant difference, meet " Chinese Pharmacopoeia " version in 2010 to the requirement of tablet on friability and hardness.
2, disintegration contrast test
Get thyroid tablet composition freeze-drying sheet prepared by above-described embodiment respectively and thyroid tablet ordinary tablet (commercially available) operates by Chinese Pharmacopoeia (2010 editions) second annex X A, its disintegration is checked.Result is as follows:
One, thyroid tablet ordinary tablet (commercially available)
Two, thyroid tablet composition freeze-drying sheet (No. 1 to No. 3 is embodiment 1, and No. 4 to No. 6 is embodiment 2)
Result judges:
Judge about the bioassay standard in disintegration of tablet time limit according to Chinese Pharmacopoeia (2010 editions) second thyroid tablet quality standard and Chinese Pharmacopoeia (2010 editions) second annex X A, thyroid tablet is no more than 15 minutes for qualified disintegration, actual measurement is 12 minutes, and thyroid tablet composition freeze-drying sheet (embodiment 1 and embodiment 2) disintegration is 6 minutes.It can thus be appreciated that thyroid tablet composition freeze-drying sheet disintegration is than reducing by 50% (6 minutes) thyroid tablet (commercially available) disintegration, so thyroid tablet composition freeze-drying sheet absorption of human body is faster, the blood drug level peaking time is shorter than thyroid tablet ordinary tablet (commercially available), its bioavailability is higher, better efficacy.
More than show and describe ultimate principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what describe in above-described embodiment and description is only preference of the present invention; be not used for limiting the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.Application claims protection domain is defined by appending claims and equivalent thereof.

Claims (2)

1. a thyroid tablet composition freeze-drying sheet, is characterized in that, is prepared from by following raw material:
2. a preparation method for thyroid tablet composition freeze-drying sheet according to claim 1, is characterized in that, comprise step as follows:
A, take the starch of component amount, add a certain amount of purified water and stir, by pH adjusting agent, the pH value of solution is controlled between 4-6, be then heated to 72 DEG C, be incubated 20 minutes, make the corn starch solution of 5 ~ 15% (W/V);
B, measure purified water 45ml, boil, add 85g sucrose, stir, after dissolving, continue to be heated to 100 DEG C, filter with purified cotton, the appropriate hot distilled water of filter is cleaned, and washing liquid and filtrate merge, and let cool, add appropriate distilled water, make full dose become 100mL, stir evenly, obtain B solution;
The solution that C, the solution and the step B that steps A are obtained obtain mixes, and fully stirs 30 minutes, is down to room temperature and obtains Semen Maydis-sucrose solution;
D, take thyroid tablet 10 grams, add in 1L Semen Maydis-sucrose solution, stir 25 ~ 35 minutes;
Medicinal liquid is sub-packed in drug-containing dish after measuring thyroid tablet content by E, medicinal liquid, each drug-containing dish dress 1.0ml;
F, the drug-containing dish that medicinal liquid is housed is put into vacuum freezing drying oven, be cooled to subzero 45 DEG C, keep 2 hours, evacuation, then 0 DEG C is warming up to gradually, keep 2 hours, then be cooled to subzero 45 DEG C, keep 2 hours, be warming up to 0 DEG C gradually again, keep 2 ~ 4 hours, then be warming up to 28 ~ 32 DEG C of dryings 4 ~ 6 hours gradually, whole process vacuum remains on 10 handkerchiefs; Finally the drug-containing dish lid of powder charge is covered tightly, and load aluminium foil bag and carry out sealing and obtain thyroid tablet composition freeze-drying sheet.
CN201410826989.1A 2014-12-25 2014-12-25 Thyroid tablet composition freeze-dried tablet and preparation method thereof Pending CN104606154A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410826989.1A CN104606154A (en) 2014-12-25 2014-12-25 Thyroid tablet composition freeze-dried tablet and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410826989.1A CN104606154A (en) 2014-12-25 2014-12-25 Thyroid tablet composition freeze-dried tablet and preparation method thereof

Publications (1)

Publication Number Publication Date
CN104606154A true CN104606154A (en) 2015-05-13

Family

ID=53140979

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410826989.1A Pending CN104606154A (en) 2014-12-25 2014-12-25 Thyroid tablet composition freeze-dried tablet and preparation method thereof

Country Status (1)

Country Link
CN (1) CN104606154A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109464411A (en) * 2017-09-07 2019-03-15 中国药科大学 A kind of thyroid tablet and its preparation process of direct compression of full-powder production
CN110420191A (en) * 2019-09-06 2019-11-08 北京兴源联合医药科技有限公司 A kind of oral disnitegration tablet comprising levothyroxine sodium

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61242556A (en) * 1985-04-19 1986-10-28 Hatoya Seika:Kk Preparation of snack using fruits
US20020173016A1 (en) * 2001-03-27 2002-11-21 Helmut Wurst High-throughput nucleic acid polymerase devices and methods for their use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61242556A (en) * 1985-04-19 1986-10-28 Hatoya Seika:Kk Preparation of snack using fruits
US20020173016A1 (en) * 2001-03-27 2002-11-21 Helmut Wurst High-throughput nucleic acid polymerase devices and methods for their use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘晓睿: "口腔速溶片的研究进展", 《中南药学》, vol. 2, no. 5, 31 May 2004 (2004-05-31), pages 196 - 198 *
段和祥,罗文艳,程奇珍: "HPLC法测定甲状腺片的含量及聚类分析*", 《中国医药科学》, vol. 1, no. 20, 31 October 2011 (2011-10-31), pages 24 - 26 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109464411A (en) * 2017-09-07 2019-03-15 中国药科大学 A kind of thyroid tablet and its preparation process of direct compression of full-powder production
CN109464411B (en) * 2017-09-07 2021-05-04 中国药科大学 Thyroid tablet produced by directly tabletting whole powder and preparation process thereof
CN110420191A (en) * 2019-09-06 2019-11-08 北京兴源联合医药科技有限公司 A kind of oral disnitegration tablet comprising levothyroxine sodium

Similar Documents

Publication Publication Date Title
CN104586881A (en) Sodium bicarbonate composition freeze-dried tablet and preparation method thereof
CN104606154A (en) Thyroid tablet composition freeze-dried tablet and preparation method thereof
CN104490750A (en) Spirolactone composition freeze-dried tablets and preparation method thereof
CN104546749A (en) Lorazepam composition freeze-dried tablet and preparation method thereof
CN104490759A (en) Cobamamide composition freeze-dried tablets and preparation method thereof
CN104523567A (en) Neostigmine bromide composition freeze-dried tablet and preparation method thereof
CN104523614A (en) Vitamin B6 composition freeze-dried tablet and preparation method thereof
CN104546683A (en) Carbocisteine composition freeze-drying tablet and preparation method thereof
CN104490830A (en) Bezafibrate composition freeze-dried tablet and preparation method thereof
CN104490829A (en) Vitamin C composition freeze-dried tablets and preparation method thereof
CN104546676A (en) Cimetidine composition freeze-drying tablet and preparation method thereof
CN104490751A (en) Hydrochlorothiazide composition freeze-dried tablets and preparation method thereof
CN104546760A (en) Thiamazole composition freeze-drying tablet and preparation method thereof
CN104490754A (en) Lyophilized tablet prepared from captopril composition and preparation method thereof
CN104490832A (en) Lyophilized tablet prepared from warfarin composition and preparation method thereof
CN104434967A (en) Zinc sulfate composite freeze-dried tablet and preparation method thereof
CN104586785A (en) Nilestriol composition freeze-dried tablets and preparation method thereof
CN104546757A (en) Busulfan composition freeze-dried tablet and preparation method thereof
CN104546762A (en) Phenolphthalein combination freeze-dried tablet and preparation method thereof
CN104606156A (en) Diethylstilbestrol composition lyophilized tablet and preparation method thereof
CN104490758A (en) Leflunomide composition freeze-dried tablets and preparation method thereof
CN104546677A (en) Inosine composition freeze-drying tablet and preparation method thereof
CN104434773A (en) Vitamin B1 composition lyophilized tablet and preparation method thereof
CN104586747A (en) Alfacalcidol composition freeze-dried tablet and preparation method thereof
CN104586780A (en) Penfluridol oral freeze-dried tablets and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150513